Filter
431
Filtered Results: 431
Text search:
Leishmaniasis
Featured
Recommendations
46
New Publications
100
Language
Document type
No document type
167
Studies & Reports
94
Guidelines
52
Strategic & Response Plan
33
Manuals
25
Videos
16
Resource Platforms
15
Fact sheets
11
Situation Updates
6
Training Material
5
Infographics
5
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
61
Latin America and the Carribbean
20
Ethiopia
18
Syria
13
India
13
Paraguay
12
Nepal
11
Colombia
11
Africa
11
Kenya
9
Bangladesh
8
Congo, Democratic Republic of
6
Middle East and North Africa
6
Bolivia
6
Uganda
6
Venezuela
5
Jordan
5
Western and Central Europe
5
Brazil
5
Sudan
5
Ghana
4
Lebanon
4
Zambia
4
Nigeria
3
Tanzania
3
East and Southern Africa
3
South Sudan
3
Iraq
3
Somalia
3
Turkey
2
Sierra Leone
2
Iran
2
Peru
2
Malawi
2
Saudi Arabia
2
South–East Asia Region
2
Argentina
2
Eastern Europe
2
Ecuador
2
Pakistan
2
North Macedonia
1
Mexico
1
Togo
1
China
1
Rwanda
1
Cameroon
1
Albania
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Qatar
1
Cambodia
1
Asia
1
Germany
1
West and Central Africa
1
North America
1
Tunisia
1
South Africa
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Liberia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
70
Public Health
42
Key Resources
16
Pharmacy & Technologies
9
Capacity Building
5
Women & Child Health
5
Toolboxes
NTDs
138
Planetary Health
27
HIV
20
Rapid Response
15
Conflict
13
COVID-19
10
Caregiver
8
Global Health Education
8
Refugee
7
TB
4
Pharmacy
4
NCDs
3
Natural Hazards
2
Ebola
2
Zika
2
AMR
2
Mental Health
1
Disability
1
Cholera
1
Health Financing Toolbox
1
Polio
1
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
Rreport of a WHO Consultative Meeting Kolkata India 2012
Leitlinie der Deutschen Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG) in Zusammenarbeit mit der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) und der Deutschen Dermatologischen Gesellschaft
2nd edition
National Guideline
El manual tiene por objetivo ampliar los conocimientos sobre la enfermedad y aspira a ser una herramienta de trabajo para que el personal de salud y los equipos de gestión presten apoyo a los ministerios de salud en sus respectivos procesos de estructuración de los servicios de salud, así como en...
La leishmaniasis es un problema creciente de salud pública en el contextomundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis cutánea que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el ...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
Leishmaniasis is a vector-borne disease that is transmitted by sandflies and caused by obligate intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals. These include the L. donovani complex with 3 species (L. donovani, L. infantum, and...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
